Moleculin Biotech, Inc. Public Float
Moleculin Biotech, Inc. (MBRX) had Public Float of $8.80 million as of 2025-12-31, per its 10-K/A filed 2026-04-14.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-14
- 2025-12-31: Entity Public Float $8.80M.
- 2025-06-30: Entity Public Float $8.80M.
- 2024-06-30: Entity Public Float $9.00M.
- 2023-06-30: Entity Public Float $16.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-12-31 | $8.80M 10-K/A · filed 2026-04-14 |
| 2025-06-30 | $8.80M 10-K · filed 2026-03-18 |
| 2024-06-30 | $9.00M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $16.00M 10-K/A · filed 2024-04-26 |
| 2022-06-30 | $40.00M 10-K · filed 2023-03-22 |
| 2021-06-30 | $101.00M 10-K · filed 2022-03-24 |
| 2020-06-30 | $52.00M 10-K · filed 2021-03-24 |
| 2019-06-30 | $48.00M 10-K · filed 2020-03-19 |
| 2018-06-30 | $38.69M 10-K · filed 2019-02-21 |
| 2017-06-30 | $32.24M 10-K · filed 2018-03-28 |
| 2016-06-30 | $27.61M 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |